These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 36304620)

  • 1. Retrospective observational study of asthma and chronic obstructive pulmonary disease prevalence and associated healthcare resource utilization in a large, integrated healthcare system.
    Collinsworth AW; Masica AL; Kudyakov R; Bayer V; Millard MW; Shaikh A
    Proc (Bayl Univ Med Cent); 2022; 35(6):737-745. PubMed ID: 36304620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Healthcare resource utilization in patients with pulmonary hypertension associated with chronic obstructive pulmonary disease (PH-COPD): a real-world data analysis.
    Weiss T; Near AM; Zhao X; Ramey DR; Banerji T; Xie H; Nathan SD
    BMC Pulm Med; 2023 Nov; 23(1):455. PubMed ID: 37990203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short- and Long-Term Impact of Prior Chronic Obstructive Pulmonary Disease Exacerbations on Healthcare Resource Utilization and Related Costs: An Observational Study (SHERLOCK).
    de Nigris E; Haughney J; Lee AJ; Nath M; Müllerová H; Holmgren U; Ding B
    COPD; 2023 Dec; 20(1):92-100. PubMed ID: 36656661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient Characteristics and Healthcare Resource Utilization Among Patients with COPD New to LAMA/LABA Fixed-Dose Combination Treatment in US-Based Real-World Practice.
    Ding B; Kallenbach L; Slipski L; Wilk A; O'Brien D; Guranlioglu D
    Int J Chron Obstruct Pulmon Dis; 2020; 15():775-786. PubMed ID: 32346288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterisation of patients with chronic obstructive pulmonary disease initiating single-device inhaled corticosteroids/long-acting β
    Czira A; Banks V; Requena G; Wood R; Tritton T; Wild R; Compton C; Duarte M; Ismaila AS
    BMJ Open Respir Res; 2022 Sep; 9(1):. PubMed ID: 36171051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Healthcare costs associated with short-acting β
    Attar-Zadeh D; Capstick T; Leese D; Arnetorp S; Rapsomaniki E; Da Costa KP; Maslova E; Xu Y; Gibson D; Quint JK
    BJGP Open; 2023 Sep; 7(3):. PubMed ID: 36759020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Respiratory pharmacotherapy use in patients newly diagnosed with chronic obstructive pulmonary disease in a primary care setting in the UK: a retrospective cohort study.
    Wurst KE; Shukla A; Muellerova H; Davis KJ
    COPD; 2014 Sep; 11(5):521-30. PubMed ID: 24945236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COPD exacerbation frequency and its association with health care resource utilization and costs.
    Dhamane AD; Moretz C; Zhou Y; Burslem K; Saverno K; Jain G; Renda A; Kaila S
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2609-18. PubMed ID: 26664109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Healthcare costs and utilization associated with muscle weakness diagnosis codes in patients with chronic obstructive pulmonary disease: a United States claims analysis.
    Trantham L; Sikirica MV; Candrilli SD; Benson VS; Mohan D; Neil D; Joshi AV
    J Med Econ; 2019 Apr; 22(4):319-327. PubMed ID: 30580639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Open triple therapy for chronic obstructive pulmonary disease: Patterns of prescription, exacerbations and healthcare costs from a large Italian claims database.
    Calabria S; Ronconi G; Dondi L; Piccinni C; Pedrini A; Esposito I; Pistelli R; Martini N
    Pulm Pharmacol Ther; 2020 Apr; 61():101904. PubMed ID: 32092473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exacerbations and healthcare resource utilization among COPD patients in a Swedish registry-based nation-wide study.
    Johansson G; Mushnikov V; Bäckström T; Engström A; Khalid JM; Wall J; Hoti F
    BMC Pulm Med; 2018 Jan; 18(1):17. PubMed ID: 29370846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COPD symptom burden: impact on health care resource utilization, and work and activity impairment.
    Ding B; Small M; Bergström G; Holmgren U
    Int J Chron Obstruct Pulmon Dis; 2017; 12():677-689. PubMed ID: 28260874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hospital and emergency department utilization associated with treatment for chronic obstructive pulmonary disease in a managed-care Medicare population.
    Simoni-Wastila L; Yang HW; Blanchette CM; Zhao L; Qian J; Dalal AA
    Curr Med Res Opin; 2009 Nov; 25(11):2729-35. PubMed ID: 19778165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative effectiveness of budesonide/formoterol combination and fluticasone/salmeterol combination among chronic obstructive pulmonary disease patients new to controller treatment: a US administrative claims database study.
    Kern DM; Davis J; Williams SA; Tunceli O; Wu B; Hollis S; Strange C; Trudo F
    Respir Res; 2015 Apr; 16(1):52. PubMed ID: 25899176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Healthcare utilization and costs among chronic bronchitis patients treated with maintenance medications from a US managed care population.
    AbuDagga A; Sun SX; Tan H; Solem CT
    J Med Econ; 2013; 16(3):421-9. PubMed ID: 23336296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of GOLD-Adherent Prescribing on COPD Symptom Burden, Exacerbations, and Health Care Utilization in a Real-World Setting.
    Mannino DM; Yu TC; Zhou H; Higuchi K
    Chronic Obstr Pulm Dis; 2015 Jun; 2(3):223-235. PubMed ID: 28848845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement in COPD management by access to asthma/COPD clinics in primary care: data from the observational PATHOS study.
    Lisspers K; Johansson G; Jansson C; Larsson K; Stratelis G; Hedegaard M; Ställberg B
    Respir Med; 2014 Sep; 108(9):1345-54. PubMed ID: 25002194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Burden Of Chronic Obstructive Pulmonary Disease (COPD) In Finland: Impact Of Disease Severity And Eosinophil Count On Healthcare Resource Utilization.
    Viinanen A; Lassenius MI; Toppila I; Karlsson A; Veijalainen L; Idänpään-Heikkilä JJ; Laitinen T
    Int J Chron Obstruct Pulmon Dis; 2019; 14():2409-2421. PubMed ID: 31749614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exacerbations and health care resource utilization in patients with airflow limitation diseases attending a primary care setting: the PUMA study.
    Montes de Oca M; Aguirre C; Lopez Varela MV; Laucho-Contreras ME; Casas A; Surmont F
    Int J Chron Obstruct Pulmon Dis; 2016; 11():3059-3067. PubMed ID: 27994446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using an electronic medical record (EMR) to conduct clinical trials: Salford Lung Study feasibility.
    Elkhenini HF; Davis KJ; Stein ND; New JP; Delderfield MR; Gibson M; Vestbo J; Woodcock A; Bakerly ND
    BMC Med Inform Decis Mak; 2015 Feb; 15():8. PubMed ID: 25880660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.